What Researchers Did
Researchers conducted a 5-year follow-up of a multicentre, open-label, randomised controlled trial (RICH-ART) to evaluate the long-term effects of hyperbaric oxygen therapy (HBO2) versus standard care for chronic radiation-induced cystitis.
What They Found
The abstract describes the 5-year follow-up of the RICH-ART trial, which aimed to assess long-term symptom relief from hyperbaric oxygen therapy for chronic radiation-induced cystitis. While the study reports on secondary outcomes, specific numerical findings regarding the long-term efficacy of HBO2 are not detailed in this abstract.
What This Means for Canadian Patients
If long-term benefits of hyperbaric oxygen therapy are confirmed, it could offer Canadian patients with chronic radiation-induced cystitis a sustained and effective treatment option. This could significantly improve quality of life for individuals suffering from this debilitating complication of pelvic radiotherapy.
Canadian Relevance
This study was conducted at five Nordic hospitals and does not have a direct Canadian connection.
Study Limitations
A limitation of the study is its open-label design, where participants and researchers were aware of treatment assignments, potentially introducing bias.